- Sosei Group Corp R&D Day TranscriptNov 10, 2023
- Q2 2023 Sosei Group Corp Earnings Presentation TranscriptAug 04, 2023
- Sosei Group Corp to Acquire Idorsia Ltd Pharmaceuticals Business in Japan and APAC TranscriptJul 20, 2023
- Sosei Group Corp Annual Shareholders Meeting TranscriptMar 23, 2023
- Full Year 2022 Sosei Group Corp Earnings Presentation TranscriptFeb 14, 2023
- Sosei Group Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Sosei Group Corp R&D Day TranscriptOct 13, 2022
- Q2 2022 Sosei Group Corp Earnings Presentation TranscriptAug 10, 2022
- Full Year 2021 Sosei Group Corp Earnings Presentation TranscriptFeb 10, 2022
- Sosei Group Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Sosei Group Corp to Discuss Newly Announced Collaboration with Neurocrine Biosciences Investor Briefing TranscriptNov 23, 2021
- Q2 2021 Sosei Group Corp Earnings Call TranscriptAug 12, 2021€11.7 (-1.68%)Earnings
- Sosei Group Corp at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Full Year 2020 Sosei Group Corp Earnings Call TranscriptFeb 15, 2021€15.4 (+7.69%)Earnings
- Sosei Group Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Sosei Group Corporation - Special Call TranscriptJan 05, 2021
- Half Year 2020 Sosei Group Corp Earnings Call TranscriptAug 13, 2020€11.1Earnings
- Sosei Group Corp Annual Shareholders Meeting TranscriptMar 25, 2020
- Sosei Group Corp at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Sosei Group Corporation - Special Call TranscriptSep 12, 2019
- Q2 2019 Sosei Group Corp Earnings Call TranscriptAug 13, 2019€22.78 (+2.61%)Earnings
- Sosei Group Corp Annual Shareholders Meeting TranscriptMar 27, 2019
Sosei Group Corp Annual Shareholders Meeting Transcript
Good morning, everyone. Thank you very much for taking time out of your busy schedule to attend this meeting. I am Shinichi Tamura, Representative, Executive Officer, President and Chairman. I will be presiding at this meeting pursuant to Paragraph 1, Article 15 of the Articles of Incorporation.
Will the 30th Annual General Shareholders' Meeting please come to order?
Today, due to the spread of COVID-19, there is a restriction -- travel restriction. So Director, David Roblin; and Executive Officers, Malcolm Weir and Tim Tasker, are not attending this meeting. I would like to ask you for your understanding.
If the shareholders seem to be having some health problems, our staffs may talk to you. And if it is considered necessary to maintain the health of the surrounding shareholders, I may ask the person to leave. So I would kindly ask you to understand. I would like to ask for your cooperation to support the smooth progress of this meeting.
We
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)